# US 2023/0265478 A1 · Methods of increasing recombinant protein yields

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265478 A1
- Document ID: US20230265478A1
- Status: Published application
- Kind: A1
- Application number: 18/007,340
- Filed: 2021-08-02
- Published: 2023-08-24
- Earliest claimed: 2020-07-31
- Assignees: Biotalys NV
- Applicants: Biotalys NV
- Inventors: Lucia Nancy Coconi Linares; Jolien Van Poucke; Charlotte Verlinde
- Web page: https://patentgrep.com/patent/US20230265478A1

## CPC

- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C07K 14/38: from Aspergillus
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C12N 1/14: Fungi (culture of mushrooms A01G18/00; as new plants A01H15/00); Culture media therefor
- C12N 1/16: Yeasts; Culture media therefor
- C12N 15/80: for fungi
- C07K 2317/14: Specific host cells or culture conditions, e.g. components, pH or temperature
- C07K 2317/569: Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
- C12N 2510/00: Genetically modified cells
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to methods for increasing yield of compounds of interest produced by microbial cells, in particular recombination proteins produced by microbial cells. The present invention also relates to the use of peptone as a yield increasing agent in a method of production of a compound of interest. The present invention provides the compounds of interest, such as recombinant proteins, obtained by the method of the invention.

## Claims

### Claim 1

A method for the production of a compound of interest comprising:
a. providing a microbial host cell comprising at least one polynucleotide coding for a compound of interest, wherein the microbial host cell is a filamentous fungal host cell;
b. culturing said microbial host cell under conditions conducive to the expression of the compound of interest, wherein the microbial host is cultured in the presence of peptone
wherein the compound of interest is an antibody or a functional fragment thereof, a carbohydrate binding domain, a heavy chain antibody or a functional fragment thereof, a single domain antibody, a heavy chain variable domain of an antibody or a functional fragment thereof, a heavy chain variable domain of a heavy chain antibody or a functional fragment thereof (VHH), a variable domain of camelid heavy chain antibody or a functional fragment thereof, a variable domain of a new antigen receptor (vNAR), a variable domain of shark new antigen receptor or a functional fragment thereof, a minibody, a nanobody, a nanoantibody, an affibody, an alphabody, a designed ankyrin-repeat domain, an anticalins, a knottins or an engineered CH2 domain, and
wherein the yield of the compound of interest is increased compared to when the microbial host cell is cultured in the absence of peptone.

### Claim 2

Use of peptone as a yield increasing agent in a method of production of a compound of interest, wherein the method comprises:
a. providing a microbial host cell capable of expressing the compound of interest, wherein the microbial host cell is a filamentous fungal host cell;
b. culturing said microbial host cell under conditions conducive to the expression of a compound of interest, wherein the microbial host is cultured in the presence of peptone
wherein the compound of interest is an antibody or a functional fragment thereof, a carbohydrate binding domain, a heavy chain antibody or a functional fragment thereof, a single domain antibody, a heavy chain variable domain of an antibody or a functional fragment thereof, a heavy chain variable domain of a heavy chain antibody or a functional fragment thereof (VHH), a variable domain of camelid heavy chain antibody or a functional fragment thereof, a variable domain of a new antigen receptor (vNAR), a variable domain of shark new antigen receptor or a functional fragment thereof, a minibody, a nanobody, a nanoantibody, an affibody, an alphabody, a designed ankyrin-repeat domain, an anticalins, a knottins or an engineered CH2 domain, and
wherein the yield of the compound of interest is increased compared to when the microbial host cell is cultured in the absence of peptone.

### Claim 3 (depends on 1, 2)

The method of claim 1 or the use of claim 2, wherein the peptone is the product of partial hydrolysis of plant, animal or yeast protein.

### Claim 4

The method or use of any preceding claim, wherein the peptone comprises from about 15% to about 35% polypeptides, from about 20% to about 40% free amino acids, from about 10% to about 30% carbohydrates, from about 5% to about 25% salts, and from about 5% to about 15% in total of vitamins, organic acids, and organic nitrogen bases, optionally wherein the peptone is free of animal derived products.

### Claim 5 (depends on 1, 2, 3, 4)

The method or use of any of claims 1 to 4, wherein the peptone is the product of partial hydrolysis of soymeal, casein, milk, meat, gelatin, or yeast.

### Claim 6

The method or use of any preceding claim, further comprising isolating a compound of interest from the culture medium.

### Claim 7

The method or use to any preceding claim, wherein the yield of the compound of interest is increased by at least about 100% when compared to when the host cell is cultured in the absence of peptone.

### Claim 8

The method or use of any preceding claim, wherein the method further comprises a step of formulating the compound of interest into a pharmaceutical composition or an agrochemical composition.

### Claim 9

The method or use of any preceding claim, wherein the filamentous fungal host cell is selected from the group consisting of Aspergillus, Acremonium, Myceliophthora, Thielavia Chrysosporium, Penicillium, Talaromyces, Rasamsonia, Fusarium or Trichoderma, preferably a species of Aspergillus niger, A. nidulans, Aspergillus awamori, Aspergillus foetidus, Aspergillus sojae, Aspergillus fumigatus, Aspergillus oryzae, Acremonium alabamense, Myceliophthora thermophila, Myceliophthora heterothallica, Thermothelomyces heterothallica, Thermothelomyces thermophilus, Thielavia terrestris, Chrysosporium lucknowense, Fusarium oxysporum, Rasamsonia emersonii, Talaromyces emersonii, Trichoderma reesei, Penicillium chrysogenum, Penicillium oxalicum and Neurospora crassa.

### Claim 10 (depends on 9)

The method or use of claim 9, wherein the microbial host cell is a cell of Trichoderma reesei.

### Claim 11

The method or use of any preceding claim, wherein the at least one polynucleotide coding for the compound of interest is operably linked to a promoter, optionally to an inducible promoter.

### Claim 12

(canceled)

### Claim 13

The method or use of any proceeding claim, wherein the antibody or functional fragment thereof of is a heavy chain variable domain of a heavy chain antibody or a functional fragment thereof (VHH).

### Claim 14 (depends on 13)

The method or use of claim 13, wherein the VHH is a VHH comprising:
a. a CDR1 comprising or consisting of a sequence selected from the group consisting of SEQ ID NOs 3, 8 and 13;
b. a CDR2 comprising or consisting of a sequence selected from the group consisting of SEQ ID NOs: 4, 9 and 14; and
c. a CDR3 comprising or consisting of a sequence selected from the group consisting of SEQ ID NOs: 5, 10 and 15.

### Claim 15 (depends on 13)

The method or use of claim 13, wherein the VHH is a VHH comprising:
d. a CDR1 comprising or consisting of the sequence of SEQ ID NO: 3, a CDR2 comprising or consisting of the sequence of SEQ ID NO: 4 and a CDR3 comprising or consisting of the sequence of SEQ ID NO: 5;
e. a CDR1 comprising or consisting of the sequence of SEQ ID NO: 8, a CDR2 comprising or consisting of the sequence of SEQ ID NO: 9 and a CDR3 comprising or consisting of the sequence of SEQ ID NO: 10 or
f. a CDR1 comprising or consisting of the sequence of SEQ ID NO: 13, a CDR2 comprising or consisting of the sequence of SEQ ID NO: 14 and a CDR3 comprising or consisting of the sequence of SEQ ID NO: 15.

### Claim 16 (depends on 13)

The method or use of claim 13, wherein the VHH is a VHH comprising or consisting of a sequence selected from the group consisting of SEQ ID NOs: 1, 2, 6, 7, 11 and 12.

### Claim 17 (depends on 13)

The method or use of claim 13, wherein the VHH is a VHH comprising or consisting of SEQ ID NO: 1.

### Claim 18 (depends on 13)

The method or use of claim 13, wherein the VHH is a VHH comprising or consisting of SEQ ID NO: 2.

### Claim 19

The method or use of any preceding claim, wherein the method comprises inserting the polynucleotide coding for a compound of interest into the microbial host cell prior to culturing the host cell.

### Claim 20

Use of a microbial host cell for the production of a compound of interest, wherein the microbial host comprises at least one polynucleotide coding for the compound of interest, and wherein the use comprises culturing the microbial host cell under conditions conducive to the expression of the compound of interest, wherein the microbial host is cultured in the presence of peptone.
wherein the microbial host cell is a filamentous fungal host cell,
wherein the compound of interest is an antibody or a functional fragment thereof, a carbohydrate binding domain, a heavy chain antibody or a functional fragment thereof, a single domain antibody, a heavy chain variable domain of an antibody or a functional fragment thereof, a heavy chain variable domain of a heavy chain antibody or a functional fragment thereof (VHH), a variable domain of camelid heavy chain antibody or a functional fragment thereof, a variable domain of a new antigen receptor (vNAR), a variable domain of shark new antigen receptor or a functional fragment thereof, a minibody, a nanobody, a nanoantibody, an affibody, an alphabody, a designed ankyrin-repeat domain, an anticalins, a knottins or an engineered CH2 domain, and
wherein the yield of the compound of interest is increased compared to when the microbial host cell is cultured in the absence of peptone.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The use of a microbial host cell of claim 20, wherein the method is the method of any one of claims 1 to 19.

### Claim 22 (depends on 4)

The method or use of claim 4, wherein the peptone is free of animal derived products.
